Learn why the next frontier in AI governance will involve real-time surveillance of algorithmic performance across institutions with guidance from Akshaya Bhagavathula and Michelle A. Williams.
- Virtual Reality Endpoints Improve Measurement Of Patients' Real-World Benefit
- Can't-Miss Advice On Selecting Your First AI-Enabled Vendor
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Phase 4 Trials: A Critical Component Of Post-Marketing Insight
Uncover how Phase 4 trials play an essential role in gathering additional real-world data on the treatment’s performance over a longer period of time and in more diverse patient populations.
-
Atlantic Research Group Builds Competitive Advantage With Medrio EDC
By using Medrio’s EDC platform, learn how Atlantic Research Group was able to achieve the flexibility needed to span multiple therapeutic areas and eliminate redundancy in documentation.
-
Regulatory Guidance For PRO Strategy In Oncology Trials
Kelly Dumais, Principal Scientific Advisor, and Jowita Marszewska, Scientific Advisor at Clario eCOA, delve into the specifics of how recent regulatory advancements are influencing PRO Strategy.
-
Opportunities For Enhancing Signal Detection In Schizophrenia Trials
Signal detection in schizophrenia trials is hindered by increased placebo response, complex rating scales, inconsistent rater performance, and data quality issues.
-
Clinical Research Data Management Can Be Easy, With A Little REST
Uncover how RESTful web services enable different systems to communicate effortlessly, breaking down traditional barriers and allowing for the flexible design of applications that can be accessed across various devices.
-
Virtual eConsent For Decentralized Trials
Virtual eConsent improves accessibility and compliance in decentralized trials, streamlining enrollment with a secure, user-friendly process for informed consent in remote research.
-
Future Predictions For Clinical Technologies
In 2025, sponsors are prioritizing configurable, interoperable solutions that integrate seamlessly across IRT, eCOA, CTMS, eConsent, and supply chain systems.
-
How Can Electronic Data Capture Better Serve Decentralized Clinical Trials?
Newer, nimbler technology providers face a steep climb if they want to convince sponsors to sunset traditional EDC in favor of direct data capture only, or a unified decentralized trial platform that everything plugs into. Will EDC evolve to fix its existing problems, or will a different type of decentralized trial platform (or single platform model) replace pick-and-pull, add-and-subtract modules of clinical trial technology?
-
Three Benefits Of Centralizing Global Content For eCOA Migration
Now, more than ever, sponsors aim to empower the global patient voice through patient-centric technologies—including providing wearable technologies and using electronic clinical outcome assessments (eCOAs) to collect patient data.
-
ePROM Implementation: 4 Best Practices For System Functionality
Explore four of the 15 system functionality considerations highlighted in an eCOA Consortium article that aim to create a more thorough and standardized approach to ePROM implementation.